This Biotech Is Developing The Next Ozempic

This Biotech Is Developing The Next Ozempic

Source: 
Motley Fool
snippet: 
  • Structure Therapeutics is working on therapies for diabetes and obesity.
  • Its efforts are still early-stage, but it has plenty of cash to keep going.
  • The competition for market share will be fierce if it launches products.